Recent evidence has highlighted the health inequalities in sleep behaviors and sleep disorders that adversely affect outcomes in select populations, including African-American and HispanicAmerican subjects. Race-related sleep health inequalities are ascribed to differences in multilevel and interlinked health determinants, such as sociodemographic factors, health behaviors, and biology. African-American and Hispanic-American subjects are admixed populations whose genetic inheritance combines two or more ancestral populations originating from different continents. Racial inequalities in admixed populations can be parsed into relevant groups of mediating factors (environmental vs genetic) with the use of measures of genetic ancestry, including the proportion of an individual's genetic makeup that comes from each of the major ancestral continental populations. This review describes sleep health inequalities in African-American and Hispanic-American subjects and considers the potential utility of ancestry studies to exploit these differences to gain insight into the genetic underpinnings of these phenotypes. The inclusion of genetic approaches in future studies of admixed populations will allow greater understanding of the potential biological basis of race-related sleep health inequalities.
Sleep science has evolved rapidly in recent decades, from refining methods to measure sleep in humans to gaining understanding of the pathophysiology and significant health impact of sleep disorders. This knowledge has led to the realization that significant health inequalities exist in sleep behaviors and sleep disorders. The World Health Organization defines health inequalities "as differences in health status or in the distribution of health determinants between different populations" that are attributable to biological or sociocultural (voluntary) variations. 1 A multitude of important health determinants exist in all populations with complex interrelationships, including socioeconomic status (SES), literacy, geographic location, age, sex, race, individual behavior, and biology.
Accumulating evidence highlights the association of selfidentified race with sleep health inequalities. [3] [4] [5] Racial differences in health outcomes are often due to cultural, social, economic, and environmental inequalities that have persisted for generations. For example, neighborhood disadvantage has been found to be a risk factor for pediatric OSA, 6 and acculturation has important effects on sleep duration. 7 However, in certain cases, racial inequalities can also be due to heritable biological differences in risk that have a genetic underpinning. If the frequency of a genetic risk factor varies substantially across ancestral populations originating from different continents (eg, African, European, Native American subjects), this variability can be exploited through the study of admixed populations whose genetic inheritance combines two or more ancestral populations. By correlating phenotype with genetic inheritance from the high-risk ancestral population, the location of the predisposing genetic alleles can be more readily identified. Thus, genetic studies of admixed populations (those who have descended from more than one ancestral population) can be a powerful tool for understanding the genetic underpinnings of biological traits, including sleeprelated phenotypes. To the extent that biology (rather than social, cultural, environmental, and economic differences) underlies racial inequalities, genetic studies of admixed populations may also provide insights into the causes of racial health inequalities.
The present review discusses the current evidence on racial health inequalities in common sleep disorders focusing on reports in admixed populations, in particular: African-American (AA) subjects, who have a mixture of African and European ancestry, and Hispanic-American (HA) subjects, who have a mixture of African, European, and Native American ancestry, compared with European-American (EA) subjects. We further outline how inclusion of genetic ancestry and techniques such as admixture mapping in association studies can improve scientific inference and identify novel genetic susceptibility loci contributing to variability in sleep phenotypes.
Inequalities in OSA
OSA is a chronic disease with a rising prevalence and considerable attendant morbidity. 8, 9 Similar to other chronic diseases such as hypertension, OSA has significant heterogeneity among afflicted individuals in terms of pathophysiology and health outcomes. 10, 11 An underlying factor that contributes to this heterogeneity is racial inequalities in prevalence, risk, and outcomes of OSA (summarized in Table 1 ). 4, Epidemiologic studies in the United States report that the prevalence of OSA is greater among AA and HA subjects compared with EA subjects. The relative risk of OSA in AA subjects is moderated by age, with the highest risk being noted in children and a resurgence of risk after the age of 65 years. 4, 12, 14, 15, 19 The conflicting data regarding higher prevalence in middle-aged AA individuals may be due to the underrepresentation of minorities in larger prospective cohorts and the use of various methods to define OSA, from questionnaires to different quantitative measures. 13, 18 An important replicated finding is that AA subjects have more severe OSA, based on quantitative metrics such as the apnea-hypopnea index and oximetry, after adjustment for obesity. 16, 17, 24, 25 However, these studies were performed in clinical populations in which bias related to access to care and delays in diagnosis may have confounded the results. 42 Although this inequality has not been specifically examined in population-based cohorts, a similar trend is suggested by the Multi-Ethnic Study of Atherosclerosis (MESA), in which the ORs for mild, moderate, and severe OSA in AA subjects compared with EA subjects showed a linear trend toward increasing risk from 1.03 to 1.35. 4 In fact, a statistically significant increase in risk was observed only for symptomatic OSA regardless of severity, suggesting a higher burden of disease. An older meta-analysis indicates that the independent effect of AA race on OSA risk and severity is small (effect sizes of 0.13 and 0.10, respectively), but AA subjects with OSA have significantly shorter sleep duration (effect size of -0.30). 22 Considering the chronic complex nature of OSA, with multiple fixed (age, sex, and craniofacial anatomy) and modifiable (obesity) risk factors, this effect size is likely to be clinically significant. 43, 44 There are fewer comparative studies on OSA prevalence between HA and EA populations. A previous report from a community cohort indicated a threefold higher prevalence of moderate to severe OSA in HA subjects. 13 In the MESA cohort, HA subjects had a higher risk of mild, moderate, and severe OSA (OR, 1.6, 1.9, and 2.1, respectively). In contrast with observations in AA subjects, the prevalence of symptomatic OSA was not significantly higher in HA subjects. 4 A report from the large Hispanic Community Health Study found that the prevalence of OSA (approximately 26%, 10%, and 4% for mild, moderate, and severe disease) was at least chestjournal.org as high as studies from predominantly EA cohorts. 8, 37 This study used home sleep apnea testing to assess OSA and included participants of seven Hispanic/Latino backgrounds; significant differences in the prevalence of moderate to severe OSA were found in men across diverse Hispanic backgrounds even after adjustment for age and obesity. Elderly and post-stroke HA subjects are at higher risk for OSA compared with their EA counterparts. 23, 26 In contrast, data from a community pediatric cohort found no difference in the prevalence of OSA between HA and EA children. 20 Consistent with the inequalities in OSA discussed earlier, poorer health outcomes have been reported in AA and HA subjects compared with EA subjects with OSA. AA individuals with OSA symptoms report higher rates of excessive daytime sleepiness as well as poorer sleep quality and physical health. 32, 33, 39 Elderly AA individuals have higher rates of abnormal 24-h blood pressure profiles (nocturnal nondipping blood pressure), independent of obesity and severity of OSA.
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Observational data from a clinical cohort and a general population survey suggest that the risk of hypertension is higher in AA subjects. 34, 36 In contrast, the risk of hypertension in OSA was not found to vary significantly according to race in the Sleep Heart Health Study, a younger community-based, predominantly EA cohort.
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Severe OSA is associated with risk of peripheral arterial disease only in AA subjects. 40 Within AA subjects, OSA is independently associated with a higher prevalence of hypertension and diabetes and in women with cellular senescence (telomere shortening). 35, 45 Moderate to severe OSA has been associated with abnormal fasting glucose levels in AA and EA populations but not in HA subjects. 38 However, HA subjects with moderate to severe OSA report poorer mental health and are at increased risk for diabetes. 31, 32, 37 The mechanisms underlying these racial inequalities in OSA are not well understood. Obesity is the strongest risk factor for OSA and is rooted in both environmental and genetic factors, varying significantly according to race. 46, 47 Although the association of genetic risk loci for obesity with OSA traits remain to be described, it is plausible that racial inequalities in OSA are mediated in part by genetic and environmental factors that drive higher rates of obesity in AA and HA subjects. The majority of studies in OSA adjust for BMI, but although the heritability estimates for BMI in AA populations are similar to EA populations, the role of fat distribution (parapharyngeal and abdominal fat) remains unclear. 48, 49 There are two reports identifying novel OSA genetic risk loci with genome-wide significance in HA subjects, 50 and another quantitative trait locus for non-rapid eye movement sleep apnea-hypopnea index in men of diverse racial backgrounds. 51 In contrast, There are few studies examining the role of craniofacial characteristics as an explanatory factor in racial OSA inequalities. Although brachycephaly is an important mediator of OSA risk in EA subjects, enlarged tongue and soft tissue are reported to mediate the propensity for OSA in AA subjects. 27, 54, 55 Although AA subjects have smaller upper airway dimensions, the heritability of this trait in AA individuals is similar to EA individuals. 43 There are few data regarding racial differences in OSA phenotypes with respect to respiratory control, upper airway collapsibility, and arousal threshold or racial differences in the physiological responses to perturbations in OSA (chronic intermittent hypoxia, sleep fragmentation, and sympathetic activation). AA groups have a lower vital capacity and more hypoxemic attenuation of baroresponse in sleep than EA groups, 14,56 but these results have not been replicated, and thus the implications of these findings remain unclear.
In summary, the prevalence and severity of OSA is higher in AA subjects and likely in HA subjects, independent of obesity. Thus far, limited data indicate that the risk of adverse health outcomes such as daytime sleepiness and cardiometabolic outcomes may also be higher in these populations. It is important to note that SES, neighborhood disadvantage, and poverty have been shown to mediate the elevated risk of OSA in AA subjects, underscoring the importance of considering and controlling for psychosocial factors in future studies of racial inequalities. 21, 30, 41 Inequalities in Insomnia
Overall, minorities are at a higher risk for insomnia compared with EA subjects. 57, 58 When self-reported insomnia is examined specifically in AA populations (and in HA populations in some studies), the prevalence is either lower than in EA subjects or largely explained chestjournal.org by SES and psychosocial stressors. 22, [59] [60] [61] [62] [63] [64] [65] The importance of SES as a mediator of sleep quality can also be gleaned from two studies conducted in college students, in which education and health between racial groups should be comparable. These studies used validated questionnaires and found equivalent or a lower prevalence of insomnia in AA groups. 66, 67 On the other hand, physician-diagnosed insomnia rates, sleep quality according to validated questionnaires, and quantitative measures indicate poorer sleep quality, particularly in urban AA populations. 60, [68] [69] [70] [71] Thus, racial inequalities related to insomnia reveal paradoxical findings, which highlight the role that complex mediators and cultural beliefs may play on self-reported symptoms (Table 2) . 22, [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] In addition to the consideration of the multilevel factors noted earlier and their interactions, future use of high throughput wearable technologies and genetic ancestry to add quantitative measures of sleep quality, bio-geographical ancestry to population surveillance, and clinical association studies will advance our understanding of racial inequalities in insomnia.
Inequalities in Narcolepsy Narcolepsy is a rare, central disorder of hypersomnolence characterized by excessive daytime sleepiness, cataplexy, hypnagogic hallucinations, sleep paralysis, and abnormal rapid eye movement sleep, and it is caused by a lack of hypocretin/orexin. 72 Genetic studies of narcolepsy reveal certain commonalities and differences across racial populations, including AA and EA subjects (Table 3) . [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] In most, but not all studies, 73 AA subjects are more frequently DRB1*15 (DR2) negative than EA subjects. [74] [75] [76] A number of studies have shown the human leukocyte antigen (HLA) DQB1*0602 rather than DRB1*15 (DR2) is the unifying, most strongly associated susceptibility allele across racial groups, including AA and EA groups. [75] [76] [77] [78] [79] In AA groups, the association is stronger with DQB1*06:02 because linkage disequilibrium (the nonrandom pattern of association between alleles at different loci within a population) is not as high between DQB1*0602 and DRB1*1501, indicating greater independence of these alleles. 76, 78 Significant effects of other HLA-DQ alleles also have been reported across racial groups. In AA subjects, narcolepsy is associated with DQB1*0602 haplotypes bearing distinct DRB1 alleles, most commonly DRB1*1503, DRB1*1501, DRB1* 1101, and DRB1*0806. 80 In addition, the DRB1*13, DQA1*0103, and DQB1*0603 haplotypes confer moderate protection in EA and AA subjects. 78 Beyond the HLA genes, other risk genes have also been implicated in the development of narcolepsy in various racial/ethnic groups (Table 3) . Associations between narcolepsy and polymorphisms in the TCRA locus, 81 in the P2RY11 gene, 82 and in the EIF3G gene 83 have been found in AA and EA populations.
A few studies conducted to date have investigated the prevalence and clinical phenotypic expression of narcolepsy according to race. The prevalence of DQB1*0602 in narcolepsy was much higher in AA subjects than in EA subjects, 72, 80 although in normal healthy adult sleepers, the prevalence of this risk allele did not differ significantly between these racial groups. 90 Notably, heterozygous or homozygous DQB1*0602 allele status influenced risk and disease expression in AA and EA subjects. 79, 91 Thus, frequency differences of the DQB1*0602 risk haplotype in racial groups indicate that environmental factors contribute to the development of narcolepsy and thus may explain differences in narcolepsy prevalence. Indeed, two studies found a higher prevalence of diagnosed narcolepsy with cataplexy in AA subjects compared with EA subjects. 84, 85 In individuals with narcolepsy with cataplexy, AA and EA groups exhibited similar symptoms, age of onset, and symptom severity but had minor differences in severe sleep paralysis, reports of cataplexy affecting the jaw and arms and being triggered by negative emotions, and reports of going blank due to sleep attacks. 86 In general clinic and hypersomnia groups, AA subjects, compared with EA subjects, were 2.8 to 4.0 times as likely to have a sleep-onset rapid eye movement period on polysomnography, after controlling for other significant variables. 87 Another study found that sex ratio, polysomnographic findings, and multiple sleep latency test measures did not differ between AA and EA subjects; AA subjects with narcolepsy had higher DQB1*0602 positivity, earlier symptom onset, and more severe daytime sleepiness, however. 72 AA subjects also had lower cerebrospinal fluid hypocretin-1 levels and lower rates of cataplexy. 72, 88 Beyond racial differences, there is a paucity of research for other health inequalities in narcolepsy. One study found a higher prevalence of diagnosed narcolepsy with cataplexy in households with lower educational attainment and lower annual income. 85 Another study found that students with a history of adverse childhood experiences had higher mean scores on subjective sleep disorder measures of narcolepsy than those without such experiences. 89 Longitudinal studies among diverse populations are needed to understand this association and to investigate potential racial inequalities in the strength of this association. 92 In summary, there are well-established racial differences in narcolepsy, with genetic underpinnings. Because both environmental and genetic factors underlie racial inequalities, genetic ancestry is an ideal method for future studies in AA groups and other admixed groups with narcolepsy; the goal is to parse the genetic aspects of race from the cultural, behavioral, and social aspects that may underlie observed phenotypic differences. Such parsing could facilitate symptom identification and diagnosis of narcolepsy.
Inequalities in Chronotype, Circadian Parameters, and Circadian Rhythm Sleep Disorders
Chronotype (also referred to as morningnesseveningness or diurnal preference) shows considerable interindividual variation and is the tendency to be an early "lark" (alert and preferring to be active early in the day) or a late "owl" (alert and preferring to be active later in the day). Several studies have found racial differences in chronotype and associated circadian parameters (Table 4) . [93] [94] [95] [96] [97] [98] [99] [100] Furthermore, chronotype differences have been found between HA subgroups 93 and between European and African subjects. 94, 95 Using experimental studies, Eastman et al 97 found robust differences between AA and EA subjects in basic properties of the circadian clock, including endogenous or free-running circadian period and the magnitude of phase advances and delays, which can contribute to morningness-eveningness, with self-identification techniques. 96 Using genetic ancestry, differences in circadian period, chronotype, and responses to shifts in the sleep-wake cycle between these two racial groups have been reported. [98] [99] [100] Of interest, circadian period correlated with percentage of African and European genetic ancestry, whereby longer circadian periods were associated with a greater percentage of European ancestry and a smaller percentage of African ancestry. There was also sex according to ancestry differences: EA women had a shorter circadian period than men, but there was no sex difference in circadian period between AA men and women. The aforementioned racial differences suggest there could be racial inequalities in disease risk, in response to jet lag or shiftwork and/or in the development of circadian rhythm sleep disorders (CRSDs). 94, 95, 97, 100 In contrast to chronotype or circadian parameters, however, there are no published Sex ratio, PSG, and measures did not differ between AA and EA subjects. ESS score was higher and age of onset of sleepiness was earlier in AA subjects. HLA-DQB1*0602 positivity was higher in AA subjects but CSF hypocretin-1 level was more frequently low (# 110 pg/ml) in AA subjects. In patients with low CSF hypocretin-1 levels, AA subjects were 4.5-fold more likely to be without cataplexy
studies of racial inequalities in CRSDs, which are extreme clinical variants of chronotype and include advanced and delayed sleep phase disorders. In summary, despite extensive knowledge of the genetics of chronotype and CRSDs, studies examining racial differences are limited but promising. Given such findings, a better understanding of the prevalence of circadian rhythm perturbations according to race and the extent to which genetic differences underlie racial differences in phenotypes such as chronotype and circadian period are critical areas of health inequalities research.
Genetic Ancestry and Admixture Mapping: Application in Understanding Sleep Health Inequality
Although outside the scope of the present review, the importance of social determinants of health in mediation of racial health inequalities must be emphasized. With respect to inequalities in health behaviors, polygenic traits, and chronic diseases, social determinants of health such as education, lifestyle, living and work situations, income, environmental pollution, public policy, discrimination, and psychosocial stress can have a profound impact and should be considered in research and in practice. 106 As an overview, a schematic conceptual model is presented (Fig 1) outlining the multilevel genesis of racial sleep health inequalities.
DNA sequence is identical across > 99.4% of sites across the human genome, and genetic diversity ranges widely across human populations, being greatest among populations with recent African ancestry. 107 The genomes of continental populations since the migration of humans out of Africa have diverged primarily because of genetic drift or natural random fluctuations of allele frequencies, with some contribution from natural As genome-wide genotypes become more readily available, global genetic ancestry is increasingly calculated by using genome-wide data, which provide improved accuracy to differentiate between closely related populations compared with specifically selected AIMs.
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Genetic ancestry is a powerful tool to search for biological contributions to health inequalities in admixed populations. 110 chestjournal.org are present. Importantly, ancestry-directed studies searching for genetic factors need to adequately control for other risk and social factors such as SES. 115 Furthermore, statistical power will depend on heritability of the trait, strength of ancestry-specific effects, and sample size. For example, African genetic ancestry estimated by using approximately 1,700 AIMs in 70 AA subjects was found to be associated with highly heritable indices of sleep depth (slow-wave sleep and delta power), although this study may have been underpowered to detect genetic ancestry effects in less heritable sleep duration and sleep efficiency traits. 116 If prevalence and severity of a sleep trait vary by ancestry, admixture mapping can identify genomic regions that track with disease in one ancestral population. 117 Admixture mapping relies on the concept of "local ancestry," in which the ancestral origin of each chromosomal segment in the mosaic genome of an individual can be quantified on the basis of polymorphisms with highly differentiated allele frequencies in the ancestral populations. 118 In a case only admixture mapping study design, affected individuals from an admixed population are scanned for regions of the genome that deviate in local ancestry from genome-wide averages. In a case-control study design or for quantitative traits, regression models are used to test the association of local ancestry with disease status or trait levels. 117 Admixture mapping has been used successfully to identify genetic associations for several traits; for example, multiple sclerosis, 119 chronic kidney disease, 120 and pharmacogenetics of relapse of acute lymphocytic leukemia. 121 Advantages of admixture mapping include the following: (1) the requirement of low-density genomic coverage to identify genetic signals, leading to a lower multiple testing burden relative to GWAS; (2) the ability to aggregate evidence from multiple independently associated variants in a region of local ancestry, even if these variants are not directly genotyped; and (3) the opportunity to detect regions with functional variants that have undergone selection in one of the ancestral populations. However, admixture mapping requires follow-up genotyping and association testing to identify specific contributing genetic variants in the identified regions. Furthermore, analysis for some HA groups remains challenging because computational methods that detect three-way admixture are rare, and ancestral populations for HA subjects are often not well known or represented in public sequence datasets. 122, 123 Newer methods combine independent association evidence from admixture mapping with single variant association tests in admixture-informed GWAS to enhance the power to detect novel genetic signals in admixed populations. 124, 125 
Conclusions
Substantial inequalities exist in a wide range of sleep phenotypes and sleep disorders that may contribute to overall health inequalities given the impact of poor sleep on a wide range of psychiatric, neurocognitive, metabolic, and cardiovascular health outcomes. Exploiting these inequalities in admixed populations such as AA and HA subjects may prove to be a powerful tool to identify underlying genetic variants predisposing to sleep disorders, thereby providing important insights into the molecular pathogenesis of these diseases. For admixture studies to be statistically robust in identifying causal genetic variants, the studies must control for cultural, socioeconomic, or other environmental differences and be adequately powered to detect differences in risk between ancestral populations due to differences in the prevalence of the causal genetic variants.
Our current understanding of OSA and insomnia both in terms of the magnitude of health inequalities and the extent to which these inequalities are due to genetic variants suggest that very large sample sizes will be required for ancestry studies to be helpful. In contrast, ancestry studies in narcolepsy and CRSDs/chronotype, because they putatively have a much larger genetic underpinning, may be more fruitful. Future studies using admixture-informed approaches hold great promise in identifying and ultimately addressing biological contributions to sleep health inequalities in these settings. Furthermore, because sleep health inequalities result in a disproportional impact on health in minority populations, it is vital that future genetic studies include these racial groups so that subsequent knowledge gained from such research can be applied directly to those populations who would derive the greatest benefit.
